ARMK Form 4: CFO Tarangelo Acquires 60.475 Dividend-Equivalent Shares

Q: What transaction did James J. Tarangelo report on Form 4 for ARMK?

He reported an acquisition of 60.475 dividend-equivalent common stock units on 08/20/2025 tied to restricted stock units.

Q: How many Aramark shares does the reporting person beneficially own after the transaction?

The Form 4 reports 48,454.846 shares beneficially owned following the reported transaction.

Q: When did the reported transaction occur and when was the Form 4 signed?

The transaction date is 08/20/2025 and the Form 4 was signed by an attorney-in-fact on 08/21/2025 .

Q: What is the nature of the securities acquired in this Form 4?

They are dividend equivalent rights that accrued on restricted stock units and vest on the same schedule as the underlying awards.

[Form 4] ARAMARK Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Aramark (ARMK) Form 4: James J. Tarangelo, SVP and Chief Financial Officer, reported an acquisition on 08/20/2025 of 60.475 common stock units described as dividend equivalent rights tied to restricted stock units; the units were recorded at a $0 price because they represent accrued dividend equivalents rather than a cash purchase. After this transaction Tarangelo beneficially owns 48,454.846 shares. The filing was signed by an attorney-in-fact on 08/21/2025. The filing notes the dividend equivalents vest on the same schedule as the underlying restricted stock awards.

Positive

Reported acquisition increases executive beneficial ownership to 48,454.846 shares
Disclosure aligns with standard Section 16 reporting and describes vesting terms for dividend equivalents

Negative

None.

Insights

TL;DR: Routine insider accrual increases executive ownership slightly via dividend equivalent settlement; immaterial for valuation.

The reported acquisition of 60.475 dividend-equivalent shares at $0 is a non-cash, compensation-related adjustment tied to existing restricted stock units. This raises the reporting person鈥檚 beneficial ownership to 48,454.846 shares, a small incremental change relative to typical executive holdings at large-cap companies. There is no cash outlay and no change to company capital structure. For investors, this is a standard compensation vesting event and not a material corporate development.

TL;DR: Compensation-related vesting disclosed properly; governance procedures appear followed.

The Form 4 discloses dividend equivalent rights credited to the CFO that vest on the same schedule as underlying restricted stock units, suggesting standard award terms and consistent reporting. The filing is timely and signed by an attorney-in-fact, indicating adherence to Section 16 reporting practices. There is no indication of accelerated vesting, related-party transactions, or other governance concerns based on this disclosure alone.

08/21/2025 - 04:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tarangelo James J.

(Last)

(First)

(Middle)

2400 MARKET STREET

(Street)

PHILADELPHIA

19103

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/20/2025		A		60.475⁽¹⁾	A	$0	48,454.846	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What transaction did James J. Tarangelo report on Form 4 for ARMK?

He reported an acquisition of 60.475 dividend-equivalent common stock units on 08/20/2025 tied to restricted stock units.

Did the reported ARMK transaction involve a cash purchase?

No. The filing shows a $0 price because these are dividend equivalent rights credited on restricted stock units, not a cash purchase.

How many Aramark shares does the reporting person beneficially own after the transaction?

The Form 4 reports 48,454.846 shares beneficially owned following the reported transaction.

When did the reported transaction occur and when was the Form 4 signed?

The transaction date is 08/20/2025 and the Form 4 was signed by an attorney-in-fact on 08/21/2025.

What is the nature of the securities acquired in this Form 4?

They are dividend equivalent rights that accrued on restricted stock units and vest on the same schedule as the underlying awards.

AG真人官方

[Form 4] ARAMARK Insider Trading Activity

Insights

FAQ

What transaction did James J. Tarangelo report on Form 4 for ARMK?

Did the reported ARMK transaction involve a cash purchase?

How many Aramark shares does the reporting person beneficially own after the transaction?

When did the reported transaction occur and when was the Form 4 signed?

What is the nature of the securities acquired in this Form 4?

NYSE:ARMK

ARMK Rankings

ARMK Latest News

ARMK Latest SEC Filings

ARMK Stock Data

AG真人官方

Trending News

[Form 4] ARAMARK Insider Trading Activity

Insights

Financial Analyst neutral

Corporate Governance Expert neutral

FAQ

What transaction did James J. Tarangelo report on Form 4 for ARMK?

Did the reported ARMK transaction involve a cash purchase?

How many Aramark shares does the reporting person beneficially own after the transaction?

When did the reported transaction occur and when was the Form 4 signed?

What is the nature of the securities acquired in this Form 4?

NYSE:ARMK

ARMK Rankings

ARMK Latest News

ARMK Latest SEC Filings

ARMK Stock Data